1-1 of 1
Kyle Crassini
Close
Sort by
Journal Articles

IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment

Yandong Shen, Kyle Crassini, Narjis Fatima, Michael O’Dwyer, Michael O’Neill, Richard I. Christopherson, Stephen P. Mulligan, O. Giles Best
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5093–5106.
https://doi.org/10.1182/bloodadvances.2019001369
Published: 2020
Includes: Supplemental data